Citius Oncology, Inc. announces preliminary topline data from its study in high-risk diffuse large B-cell lymphoma patients
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
This Phase 1 clinical trial aims to evaluate the safety and preliminary efficacy of Lymphir™ (research code E7777) when administered prior to commercial chimeric antigen receptor T-cell therapy.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Futures Hotspot Tracking
金十•2026/04/16 02:22
Ethereum Foundation member Trent Van Epps announces departure
AIcoin•2026/04/16 02:19
Aave Labs launches AI-powered governance security review system Aave Checkpoint
ForesightNews•2026/04/16 02:16
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$74,745.4
+0.30%
Ethereum
ETH
$2,354.45
+0.95%
Tether USDt
USDT
$1
-0.01%
XRP
XRP
$1.4
+2.60%
BNB
BNB
$622.74
+0.55%
USDC
USDC
$0.9998
+0.00%
Solana
SOL
$84.85
+1.18%
TRON
TRX
$0.3260
+0.58%
Dogecoin
DOGE
$0.09533
+1.98%
Hyperliquid
HYPE
$44.5
+0.06%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now